ArticleBMC psychiatry2026
Development and validation of a clinical prediction model and risk score for 30-day psychiatric readmission in the United Arab Emirates.
Article in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPsychiatric readmission within 30 days of discharge is an important indicator of healthcare quality. Despite the global proliferation of prediction models, no validated tool exists for Middle Eastern or Gulf Cooperation Council populations, where distinctive demographic characteristics and service configurations may limit the transportability of models developed elsewhere.
methodsThis retrospective cohort study analysed 14,994 psychiatric inpatient admissions from 9,263 unique patients at a tertiary psychiatric facility in the United Arab Emirates (2018-2025), using electronic health record data. The cohort was randomly split into development (70%) and validation (30%) samples. Missing marital status data (28.2%) were addressed using multiple imputation with chained equations (20 imputed datasets). Nonlinearity of count-based predictors was addressed using log-transformations. LASSO logistic regression with ten-fold cross-validation was used for predictor selection and model fitting, with results pooled across imputed datasets. A simplified integer-based clinical risk score was derived from categorised predictors. Model performance was benchmarked against recalibrated LACE and READMIT-subset indices.
resultsThe 30-day readmission rate was 10.6% (n = 1,583). LASSO regression identified prior psychiatric admissions, schizoaffective disorder, Charlson Comorbidity Index, first-generation antipsychotic prescription, long-acting injectable antipsychotic prescription (protective), emergency admission, emergency department visits, and antidepressant prescription as the principal predictors. Marital status was not consistently retained after multiple imputation with married as the reference category, likely reflecting the large proportion of missing data and the characteristics of the unrecorded group. The model demonstrated modest discrimination (AUC 0.649, 95% CI 0.623-0.678 in validation), significantly outperforming both the LACE index (AUC 0.557, p < 0.001) and READMIT-subset (AUC 0.604, p < 0.001). Temporal validation (2018-2023 training, 2024-2025 testing) yielded stable performance (AUC 0.676). A three-tier risk score stratified patients into low (6.7%), medium (10.0%), and high (18.0%) readmission probability groups.
conclusionThis study presents the first psychiatric readmission prediction model from the Middle East, developed using penalised regression and multiple imputation. The locally derived model outperformed imported indices, and the clinical risk score offers a practical tool for identifying high-risk patients who may benefit from intensified discharge planning and transitional care. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.